Choose which categories of cookies you allow. Strictly necessary cookies are always on.
Required for core site functionality, security and your session. Always active.
Help us understand how visitors use the site (e.g. Google Analytics) so we can improve it.
Used to measure campaigns and show you relevant ads on other sites (e.g. LinkedIn, Google Ads).
Diagnostic Imaging Market Analysis size 2021 was recorded $44260 Million whereas by the end of 2026 it will reach $55050.30 Million. According to the author, by 2033 Diagnostic Imaging market size will become $74716 Million. Diagnostic Imaging market will be growing at a CAGR of 4.46% during 2026 to 2033. Download a free sample with data verified by Supriya Yadav
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Type Segment | CT Scanners, X-ray Imaging Systems, MRI Systems, Ultrasound Imaging Systems, Nuclear Imaging Systems, Mammography Systems |
| Application Segment | Obstetrics and Gynecology Health, Orthopedics and Musculoskeletal, Neuro and Spine, Cardiovascular and Thoracic, General Imaging, Breast Health, Others |
| End User Segment | Hospitals, Hospital Pharmacies, Drug Stores, Online drug stores |
|---|---|
| Regions & Countries |
|
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global | $ 44.26 Billion | $ 52.7 Billion | $ 74.72 Billion | 4.46% |
| North America | $ 17.57 Billion | $ 20.45 Billion | $ 27.87 Billion | 3.946% |
| United States | $ 12.04 Billion | $ 13.8 Billion | $ 18.23 Billion | 3.537% |
| Canada | $ 4.09 Billion | $ 4.87 Billion | $ 6.88 Billion | 4.43% |
| Mexico | $ 1.44 Billion | $ 1.78 Billion | $ 2.76 Billion | 5.639% |
| Europe | $ 12.35 Billion | $ 14.49 Billion | $ 20.02 Billion | 4.124% |
| United Kingdom | $ 2.45 Billion | $ 2.99 Billion | $ 4.45 Billion | 5.102% |
| France | $ 1.53 Billion | $ 1.81 Billion | $ 2.54 Billion | 4.331% |
| Germany | $ 2.19 Billion | $ 2.62 Billion | $ 3.78 Billion | 4.688% |
| Italy | $ 0.91 Billion | $ 1.03 Billion | $ 1.26 Billion | 2.579% |
| Russia | $ 0.64 Billion | $ 0.73 Billion | $ 0.94 Billion | 3.322% |
| Spain | $ 1.26 Billion | $ 1.39 Billion | $ 1.72 Billion | 2.702% |
| Sweden | $ 0.62 Billion | $ 0.68 Billion | $ 0.88 Billion | 3.269% |
| Denmark | $ 0.67 Billion | $ 0.75 Billion | $ 0.96 Billion | 3.087% |
| Switzerland | $ 0.46 Billion | $ 0.51 Billion | $ 0.64 Billion | 2.964% |
| Luxembourg | $ 0.21 Billion | $ 0.23 Billion | $ 0.28 Billion | 2.4% |
| Rest of Europe | $ 1.42 Billion | $ 1.75 Billion | $ 2.56 Billion | 4.858% |
| Asia Pacific | $ 8.59 Billion | $ 10.75 Billion | $ 16.74 Billion | 5.688% |
| China | $ 3.18 Billion | $ 4.12 Billion | $ 6.76 Billion | 6.396% |
| Japan | $ 1.8 Billion | $ 2.12 Billion | $ 2.91 Billion | 4.061% |
| South Korea | $ 1.01 Billion | $ 1.26 Billion | $ 1.93 Billion | 5.461% |
| India | $ 0.94 Billion | $ 1.25 Billion | $ 2.21 Billion | 7.409% |
| Australia | $ 0.48 Billion | $ 0.58 Billion | $ 0.82 Billion | 4.413% |
| Singapore | $ 0.28 Billion | $ 0.33 Billion | $ 0.44 Billion | 3.637% |
| Taiwan | $ 0.31 Billion | $ 0.37 Billion | $ 0.54 Billion | 4.89% |
| South East Asia | $ 0.44 Billion | $ 0.54 Billion | $ 0.8 Billion | 5.15% |
| Rest of APAC | $ 0.15 Billion | $ 0.19 Billion | $ 0.33 Billion | 6.751% |
| South America | $ 2.39 Billion | $ 2.9 Billion | $ 4.18 Billion | 4.696% |
| Brazil | $ 1.1 Billion | $ 1.33 Billion | $ 1.89 Billion | 4.494% |
| Argentina | $ 0.39 Billion | $ 0.47 Billion | $ 0.65 Billion | 4.203% |
| Colombia | $ 0.21 Billion | $ 0.27 Billion | $ 0.44 Billion | 6.169% |
| Peru | $ 0.15 Billion | $ 0.19 Billion | $ 0.29 Billion | 5.685% |
| Chile | $ 0.28 Billion | $ 0.34 Billion | $ 0.5 Billion | 5.027% |
| Rest of South America | $ 0.26 Billion | $ 0.31 Billion | $ 0.42 Billion | 3.936% |
| Middle East | $ 1.95 Billion | $ 2.37 Billion | $ 3.51 Billion | 5.029% |
| Saudi Arabia | $ 0.73 Billion | $ 0.91 Billion | $ 1.42 Billion | 5.696% |
| Turkey | $ 0.41 Billion | $ 0.49 Billion | $ 0.71 Billion | 4.772% |
| UAE | $ 0.33 Billion | $ 0.41 Billion | $ 0.6 Billion | 5.106% |
| Egypt | $ 0.22 Billion | $ 0.27 Billion | $ 0.38 Billion | 4.674% |
| Qatar | $ 0.11 Billion | $ 0.13 Billion | $ 0.16 Billion | 3.186% |
| Rest of Middle East | $ 0.15 Billion | $ 0.17 Billion | $ 0.23 Billion | 3.714% |
| Africa | $ 1.42 Billion | $ 1.74 Billion | $ 2.39 Billion | 4.059% |
| East Africa | xxxx | xxxx | xxxx | xxxx |
| West Africa | xxxx | xxxx | xxxx | xxxx |
| North Africa | xxxx | xxxx | xxxx | xxxx |
| South Africa | $ 0.53 Billion | $ 0.64 Billion | $ 0.83 Billion | 3.295% |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →In terms of revneue, the ultrasound type segment held the largest share of 31.7% in 2022. Ultrasound imaging is a non-invasive and radiation-free imaging modality, which makes it safer and more accessible than other types. Ionizing radiation has the potential to damage cells and DNA, which is why it is associated with certain risks, especially with repeated or high-dose exposures. Ultrasound's use of sound waves instead of ionizing radiation makes it a safer imaging option. The absence of ionizing radiation reduces the potential risks to patients and allows for repeated examinations when necessary. This safety advantage has contributed to the widespread use and acceptance of ultrasound imaging across various medical specialties. CT Scanners X-ray Imaging Systems MRI Systems Ultrasound Imaging Systems Nuclear Imaging Systems Mammography Systems
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Canon Medical launched the Vantage Fortain MRI System at ECR 2022. This MRI system features innovative workflow solutions, image enhancements, and accelerated scan technology, which together contributes to reducing the time required for MRI procedures.
(Source: https://eu.medical.canon/News/PressRelease/Detail/118991-834 )
Wipro GE Healthcare launched the next-generation revolution aspire CT scanner. Revolution Aspire is an advanced imaging solution designed and manufactured end-to-end in India.
| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| GE Healthcare | ••• | ••• | ••• | ••• |
| Koninklijke Philips N.V. | ••• | ••• | ••• | ••• |
| Canon Medical Systems Corporation | ••• | ••• | ••• | ••• |
| Siemens Healthineers | ••• | ••• | ••• | ••• |
| Koninklijke Philips N.V | ••• | ••• | ••• | ••• |
| Esaote | ••• | ••• | ••• | ••• |
| Hologic Inc. | ••• | ••• | ••• | ••• |
| Samsung Medison Co. Ltd. | ••• | ••• | ••• | ••• |
| Koning Corporation | ••• | ••• | ••• | ••• |
| Mindray Medical International | ••• | ••• | ••• | ••• |
| PerkinElmer Inc. | ••• | ••• | ••• | ••• |
| FUJIFILM VisualSonics Inc. | ••• | ••• | ••• | ••• |
| Cubresa Inc | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →The global diagnostic imaging market is on a steady growth trajectory, projected to expand from $44.26 billion in 2021 to $74.716 billion by 2033, at a CAGR of 4.46%. This growth is primarily fueled by the rising prevalence of chronic diseases, a globally aging population, and significant technological advancements in imaging modalities. Innovations such as artificial intelligence (AI) for image analysis, the development of portable and point-of-care devices, and the integration of hybrid imaging systems are revolutionizing diagnostic capabilities. North America currently dominates the market, but the Asia-Pacific region is poised to exhibit the fastest growth. Key challenges, including the high cost of equipment and a shortage of skilled professionals, continue to temper market expansion, necessitating strategic focus on cost-effective solutions and workflow automation.
Manufacturers should prioritize investment in AI and machine learning to automate image analysis and enhance diagnostic precision, addressing the global shortage of radiologists. Developing a tiered portfolio of products, including cost-effective and portable systems, is crucial to penetrate high-growth emerging markets. Furthermore, companies should focus on creating integrated, enterprise-wide imaging solutions that improve workflow efficiency and support value-based care models. Building strategic partnerships with local distributors and healthcare providers will be key to navigating regional regulatory landscapes and expanding market access.
Diagnostic imaging, also called medical imaging, is a technique and a process used to visualize the function of some organs or tissues as well as the interior of an individual for clinical analysis and medical intervention. Diagnostic health imaging technology has altered healthcare and enables earlier diagnosis of medical conditions, decreases the need for unnecessary invasive exploratory procedures, and improves patient outcomes. Diagnostic imaging refers to various methods of viewing the inside of the body to determine the causes of an illness or injury and confirm a diagnosis. Doctors also use it to see how well a patient’s body responds to treatment for a fracture or illness. Diagnostic imaging is essential in modern healthcare because it offers useful information for clinical decision-making, guiding treatment plans, and evaluating treatment outcomes. It helps to detect fractures, tumors, infections, blockages, and other abnormalities, enabling healthcare providers to develop appropriate treatment plans and interventions.
The Diagnostic Imaging market operates within the broader Healthcare and Medical Technology Industry, forming a critical segment of Medical Diagnostics. It provides essential visual representations of the body's interior, serving the crucial need for early and accurate diagnosis of a wide range of diseases and for guiding medical interventions.
Historical Growth: The global diagnostic imaging market has shown significant growth, expanding from $44.26 billion in 2021 to an estimated $55.05 billion in 2026, with projections to reach $74.716 billion by 2033.
Current Market Leader: North America currently holds the largest global market share, valued at $21,253.95 Million in 2026 and representing approximately 38.8% of the global market, with the United States as the dominant force accounting for 26.19% of the global market.
Leading Technologies & Segments: Artificial intelligence (AI) and machine learning are fundamental drivers for enhancing diagnostic accuracy and workflow efficiency. Simultaneously, the market is shifting towards portable and point-of-care (POC) imaging solutions, alongside the adoption of cutting-edge hybrid imaging systems like PET/MRI.
Overall Projection: The global diagnostic imaging market is projected to reach $74.716 billion by 2033, growing at an aggregate CAGR of 4.46%.
Fastest-Growing Region: The Asia Pacific region is poised to exhibit the fastest growth, projected to expand at a CAGR of 5.688%, driven by countries like China and India which represent 7.81% and 2.37% of the global market respectively.
Primary Growth Driver: This future growth will primarily be driven by the rising prevalence of chronic diseases, a globally aging population, and significant technological advancements such as artificial intelligence (AI) for image analysis, and the development of portable and point-of-care devices.
Supriya is a Team Lead at Cognitive Market Research & Consulting, leading research initiatives and strategic intelligence projects across the Healthcare, Pharmaceuticals, and Medical Devices & Consumables sectors. With more than two years of experience in market research and data analysis, she plays a key role in helping organizations navigate complex healthcare ecosystems, identify emerging opportunities, and make informed business decisions through data-driven insights and market intelligence.
Combining expertise in both primary and secondary research methodologies with a strong academic foundation in Marketing and Finance, Supriya oversees the execution of market assessments, competitive intelligence studies, forecasting models, stakeholder interviews, trend analysis, and custom consulting engagements. She collaborates with healthcare providers, pharmaceutical manufacturers, medical device companies, industry experts, and other key stakeholders to gather firsthand market perspectives while validating findings through extensive research. Her ability to interpret clinical, commercial, and market data enables clients to better understand industry developments, regulatory influences, innovation trends, and competitive dynamics.
In her leadership role, she manages end-to-end research projects and guides cross-functional teams in delivering high-quality market reports, consulting solutions, and strategic studies. Her expertise in market estimation, forecasting, and analytical modeling helps organizations evaluate market potential, assess growth opportunities, strengthen competitive positioning, and support strategic planning initiatives. By transforming complex healthcare and life sciences data into actionable business intelligence, she enables clients to make confident decisions in rapidly evolving market environments.
Driven by a passion for healthcare innovation and continuous professional development, Supriya remains committed to staying ahead of industry trends, technological advancements, and changing market conditions. Her leadership, analytical mindset, and dedication to research excellence help organizations mitigate risks, capitalize on emerging opportunities, and achieve sustainable growth across the global healthcare and life sciences landscape.
★ Reviews
Rate this report
| Type | CT Scanners, X-ray Imaging Systems, MRI Systems, Ultrasound Imaging Systems, Nuclear Imaging Systems, Mammography Systems |
|---|---|
| Application | Obstetrics and Gynecology Health, Orthopedics and Musculoskeletal, Neuro and Spine, Cardiovascular and Thoracic, General Imaging, Breast Health, Others |
| End User | Hospitals, Hospital Pharmacies, Drug Stores, Online drug stores |
| List of Competitors | GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Siemens Healthineers, Koninklijke Philips N.V, Esaote, Hologic Inc., Samsung Medison Co. Ltd., Koning Corporation, Mindray Medical International, PerkinElmer Inc., FUJIFILM VisualSonics Inc., Cubresa Inc |
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Diagnostic Imaging Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
The market for Diagnostic Imaging is a pivotal and rapidly evolving sector that provides an overview of what diagnostic imaging entails, the components used, and its diverse applications. Let’s find out the key factors boosting the market’s growth.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Diagnostic Imaging Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the diagnostic imaging market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
